Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2013,NCI,5R01CA109545-07,,Receptor Cross-Talk in Early Metastatic Dissemination,"STACK, MARY",UNIVERSITY OF NOTRE DAME,IN,"$280,166"
Ovarian Cancer,2013,OD,1S10OD012304-01,,Orbitrap Elite High-Resolution Mass Spectrometer for Proteomics and Metabolomics,"HAWKE, DAVID",UT MD ANDERSON CANCER CTR,TX,"$877,433"
Ovarian Cancer,2013,NCI,5F31CA165853-02,,Therapeutic Targeting of Novel Antifolates to Solid Tumors via Folate Receptor,"MITCHELL, SHERMAINE",WAYNE STATE UNIVERSITY,MI,"$37,021"
Ovarian Cancer,2013,NCI,5R01CA123233-06,,Regulation of JNK-signaling molecules by the gep oncogenes,"DHANASEKARAN, DANNY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$226,812"
Ovarian Cancer,2013,NCI,7R01CA077429-14,,Basis for Lymphomagenesis in Akt2 Transgenic Mice,"TESTA, JOSEPH",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$374,544"
Ovarian Cancer,2013,NCI,5R01CA079716-14,,Ovarian Cancer: Epithelial Dedifferentiation,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$306,828"
Ovarian Cancer,2013,NCI,5R01CA104996-09,,Promoting Tumor Immunity by Cross-linking B7-DC,"PEASE, LARRY",MAYO CLINIC ROCHESTER,MN,"$224,952"
Ovarian Cancer,2013,NCI,5R01CA142838-04,,Role of redox state in ovarian cancer response to cisplatin,"DANIEL, LARRY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$275,386"
Ovarian Cancer,2013,NCI,5R01CA144057-09,,Evaluation of Vectors based on group B adenoviruses,"LIEBER, ANDRE",UNIVERSITY OF WASHINGTON,WA,"$855,992"
Ovarian Cancer,2013,NCI,5R01CA129927-06,,Discovery of Gene Expression Signatures in Cancer Stroma,"WEST, ROBERT",STANFORD UNIVERSITY,CA,"$356,582"
Ovarian Cancer,2013,NCI,5R01CA158415-02,,Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$451,626"
Ovarian Cancer,2013,NCI,5R21CA165807-02,,Tumor Suppressor Role of ARID1A,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$198,725"
Ovarian Cancer,2013,NCI,5R01CA138628-04,,Role of the BMP SMADs in Oncogenesis,"PANGAS, STEPHANIE",BAYLOR COLLEGE OF MEDICINE,TX,"$333,108"
Ovarian Cancer,2013,NCI,5R01CA133057-05,,Prognostic markers for ovarian cancer,"MOK, SAMUEL",UT MD ANDERSON CANCER CTR,TX,"$291,367"
Ovarian Cancer,2013,NCI,5R01CA124951-04,,Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy,"FANG, BINGLIANG",UT MD ANDERSON CANCER CTR,TX,"$291,367"
Ovarian Cancer,2013,NCI,5R01CA142776-04,,"The role of microRNA, mir-30d, in the initiation and progression of cancer","ZHANG, LIN",UNIVERSITY OF PENNSYLVANIA,PA,"$302,718"
Ovarian Cancer,2013,NIEHS,5R21ES020538-02,,"Novel triplex-engineered, BRCA1-mutated cell lines for research","GLAZER, PETER",YALE UNIVERSITY,CT,"$244,326"
Ovarian Cancer,2013,NCI,1R01CA172743-01,,Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients,"SUTPHEN, REBECCA",UNIVERSITY OF SOUTH FLORIDA,FL,"$570,119"
Ovarian Cancer,2013,NCI,5P30CA014236-39,6412,Breast and Ovarian Oncology,"BERCHUCK, ANDREW",DUKE UNIVERSITY,NC,"$25,111"
Ovarian Cancer,2013,NCI,1R15CA173452-01,,Interleukin-8 Regulation by Proteasome and Nuclear IkB in Cancer and Inflammation,"VANCUROVA, IVANA",ST. JOHN'S UNIVERSITY,NY,"$495,000"
Ovarian Cancer,2013,NCI,1R03CA173531-01,,LncRNA Pathways as Novel Diagnostic Biomarkers Derived from the Stroma of Epithel,"GAYTHER, SIMON",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$82,000"
Ovarian Cancer,2013,NCI,1R03CA172944-01,,Urinary metalloproteinases and ovarian cancer risk in a prospective cohort,"BUTLER, LESLEY",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$93,703"
Ovarian Cancer,2013,NICHD,5R01HD057110-06,,Molecular Pathways Controlling Ovarian Gene Expression,"STOCCO, CARLOS",UNIVERSITY OF ILLINOIS,IL,"$274,001"
Ovarian Cancer,2013,NIGMS,5SC1GM082340-04,,The Fulvene Approach to the Syntheses of Antitumor Agents,"ERDEN, IHSAN",SAN FRANCISCO STATE UNIVERSITY,CA,"$256,631"
Ovarian Cancer,2013,NCI,5R01CA148747-04,,Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer,"CLIBY, WILLIAM",MAYO CLINIC ROCHESTER,MN,"$298,367"
Ovarian Cancer,2013,NCI,5R01CA142832-04,,Novel Biomarkers in Ovarian Cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$326,708"
Ovarian Cancer,2013,NCI,5R01CA108990-09,,Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$534,168"
Ovarian Cancer,2013,NCI,5R01CA101850-09,,ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING,"BAE, YOU",UNIVERSITY OF UTAH,UT,"$247,262"
Ovarian Cancer,2013,NCI,5R01CA095175-10,,Analysis of BRCA1 recombination functions,"SCULLY, RALPH",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$277,509"
Ovarian Cancer,2013,NCI,5R01CA131200-05,,Regulation of Ovarian Cancer Multidrug Resistance by MAP Kinases,"EBLEN, SCOTT",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$278,350"
Ovarian Cancer,2013,NCI,5R01CA149429-04,,The Mitochondrial Genome and Ovarian Cancer Risk,"PHELAN, CATHERINE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$551,352"
Ovarian Cancer,2013,NCI,5R01CA109298-09,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UT MD ANDERSON CANCER CTR,TX,"$297,324"
Ovarian Cancer,2013,NCI,5R01CA102707-09,,Inhibition  of Cytochrome c-induced Caspase Activation,"KORNBLUTH, SALLY",DUKE UNIVERSITY,NC,"$247,272"
Ovarian Cancer,2013,NCI,5R01CA099985-07,,Human Tregs in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN,MI,"$203,951"
Ovarian Cancer,2013,NCI,5R01CA157176-03,,"Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer","BICKELL, NINA",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$323,764"
Ovarian Cancer,2013,NCI,5R01CA163345-02,,Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics,"BUCKANOVICH, RONALD",UNIVERSITY OF MICHIGAN,MI,"$303,303"
Ovarian Cancer,2013,NCI,5R01CA108970-09,,CD4+ Memory T-Cells in Human Tumor Microenvironment,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$278,916"
Ovarian Cancer,2013,NCI,5R21CA159002-02,,Peptide-targeted alpha-particle emitting phage for ovarian cancer therapy.,"QUINN, THOMAS",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$150,578"
Ovarian Cancer,2013,NCI,5R01CA163462-02,,MUC1 Roles in ovarian cancer pathogenesis and immune therapy,"VLAD, ANDA",MAGEE-WOMEN'S RES INST AND FOUNDATION,PA,"$271,239"
Ovarian Cancer,2013,NCI,2R01CA097061-10A1,,Chemical genetic profiling of engineered tumor cells,"STOCKWELL, BRENT",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$350,176"
Ovarian Cancer,2013,NCI,9R01CA174470-22A1,,Stimulation of Tumorigenesis by NKG2D,"SPIES, THOMAS",FRED HUTCHINSON CAN RES CTR,WA,"$646,415"
Ovarian Cancer,2013,NCI,2R01CA047135-23A1,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$678,352"
Ovarian Cancer,2013,NHLBI,5R21HL113439-02,,Regulation of Macrophage Reverse Cholesterol Transport by BRCA1,"SCHULMAN, IRA",UNIVERSITY OF VIRGINIA,VA,"$219,912"
Ovarian Cancer,2013,NCI,1UM1CA173642-01,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CAN RES CTR,WA,"$1,894,768"
Ovarian Cancer,2013,NCI,1U43CA162454-01A1,,Targeted Docetaxel-Nanocolloid for the Treatment of Ovarian Cancer,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$288,302"
Ovarian Cancer,2013,NCI,1K99CA166228-01A1,,A Pathway-based Approach to Investigate Oncogenic Mechanisms in Ovarian Cancer,"GATZA, MICHAEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$99,860"
Ovarian Cancer,2013,NIBIB,5R01EB007268-06,,Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity,"YANG, JENNY",GEORGIA STATE UNIVERSITY,GA,"$408,245"
Ovarian Cancer,2013,NCI,5R01CA140323-04,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$305,447"
Ovarian Cancer,2013,NCI,5R01CA133117-05,,Role of the Mullerian Tract in Ovarian Cancer Development,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$306,503"
Ovarian Cancer,2013,NCI,5R01CA136549-05,,Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,"LU, XIONGBIN",UT MD ANDERSON CANCER CTR,TX,"$298,935"
Ovarian Cancer,2013,NCI,5R01CA039742-29,,Epidemiology of Cancer in a Cohort of Older Women,"LAZOVICH, DEANN",UNIVERSITY OF MINNESOTA,MN,"$414,310"
Ovarian Cancer,2013,NCI,5R01CA141078-04,,Multifunctional roles of homeobox gene DLX4 in ovarian cancer,"NAORA, HONAMI",UT MD ANDERSON CANCER CTR,TX,"$298,934"
Ovarian Cancer,2013,NCI,5R01CA131965-05,,Defining a Pre-Malignant Phenotype in Fallopian Tube Epithelium,"SWISHER, ELIZABETH",UNIVERSITY OF WASHINGTON,WA,"$295,150"
Ovarian Cancer,2013,NCI,1R21CA167038-01A1,,MiR-182 overexpression in early tumorigenesis of high grade serous carcinoma,"WEI, JIAN-JUN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$201,623"
Ovarian Cancer,2013,NIEHS,1R21ES020411-01A1,,"Cancer induction in the ovary by an environmental pollutant, dibenzo[a,l]pyrene","CHEN, KUN-MING",PENNSYLVANIA STATE UNIVERSITY,PA,"$229,500"
Ovarian Cancer,2013,NCI,1R21CA156021-01A1,,Elafin as a biomarker in serous ovarian cancers and basal-like breast tumors,"DRAPKIN, RONNY",DANA-FARBER CANCER INST,MA,"$224,499"
Ovarian Cancer,2013,NCI,1R03CA173834-01,,Genetic Risk Prediction in Primary Care,"BISWAS, SWATI",UNIVERSITY OF TEXAS DALLAS,TX,"$84,664"
Ovarian Cancer,2013,NCI,5R01CA099471-09,,Gonadotropins & Cox-2 in Ovarian Cancer Prevention,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$353,498"
Ovarian Cancer,2013,NCI,5R01CA115780-08,,Diagnosis of Ovarian Cancer by Confocal Microendoscopy,"GMITRO, ARTHUR",UNIVERSITY OF ARIZONA,AZ,"$260,253"
Ovarian Cancer,2013,NCI,5R01CA134424-05,,A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc,"KOSTUK, RAYMOND",UNIVERSITY OF ARIZONA,AZ,"$366,555"
Ovarian Cancer,2013,NCI,5R01CA157664-03,,Initiation and evolution of the ovarian cancer microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$333,701"
Ovarian Cancer,2013,NCI,5R01CA155025-03,,The role of a novel BRCA1 associated complex in DNA damage response and tumor sup,"WANG, BIN",UT MD ANDERSON CANCER CTR,TX,"$308,179"
Ovarian Cancer,2013,NCI,5R01CA158119-02,,Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$514,415"
Ovarian Cancer,2013,NCI,5R01CA148826-03,,Characterizing Notch3 Signaling in Ovarian Cancer,"WANG, TIAN-LI",JOHNS HOPKINS UNIVERSITY,MD,"$319,882"
Ovarian Cancer,2013,NCI,5R01CA086984-14,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF NOTRE DAME,IN,"$277,736"
Ovarian Cancer,2013,NCI,5P30CA077598-15,5757,Women's Cancer,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA,MN,"$77,836"
Ovarian Cancer,2013,NCI,5R01CA158881-03,,Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$596,489"
Ovarian Cancer,2013,NCI,5R01CA031841-33,,Synthetic Studies on Tumor Promoters and Inhibitors,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$305,768"
Ovarian Cancer,2013,NCI,5R01CA154460-03,,CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$324,596"
Ovarian Cancer,2013,NCI,5R03CA167765-02,,Effect of exercise on cortisol dysregulation in ovarian cancer survivors,"CARTMEL, BRENDA",YALE UNIVERSITY,CT,"$78,197"
Ovarian Cancer,2013,NCI,5U54CA113001-09,8572,Interrogating Epigenetic Changes in Cancer Genomes,"HUANG, TIM",OHIO STATE UNIVERSITY,OH,"$1,436,990"
Ovarian Cancer,2013,NIBIB,5R21EB014572-02,,Intracellular delivery of proapoptotic peptide drugs for the treatment of cancer,"STAYTON, PATRICK",UNIVERSITY OF WASHINGTON,WA,"$193,900"
Ovarian Cancer,2013,NCI,5R01CA142081-04,,Epidemiology of Ovarian Cancer in African-American Women,"SCHILDKRAUT, JOELLEN",DUKE UNIVERSITY,NC,"$453,064"
Ovarian Cancer,2013,NCI,5R01CA137041-05,,MicroRNAs in Human Ovarian Cancer,"CHENG, JIN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$315,962"
Ovarian Cancer,2013,NCI,5R01CA136494-05,,Molecular mechanism of antiangiogenic properties of gold nanoparticle,"MUKHERJEE, PRIYABRATA",MAYO CLINIC ROCHESTER,MN,"$257,291"
Ovarian Cancer,2013,NCI,5R01CA138556-05,,Impact of exercise on ovarian cancer prognosis,"IRWIN, MELINDA",YALE UNIVERSITY,CT,"$550,148"
Ovarian Cancer,2013,NCI,9R01CA174643-06,,The role of ERRalpha/PGC-1 in disease pathogenesis,"MCDONNELL, DONALD",DUKE UNIVERSITY,NC,"$322,347"
Ovarian Cancer,2013,NCI,7R01CA136596-05,,"The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis","CONNOLLY, DENISE",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$303,948"
Ovarian Cancer,2013,NCI,5K08CA148887-04,,Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer,"KHABELE, DINEO",VANDERBILT UNIVERSITY MED CTR,TN,"$159,084"
Ovarian Cancer,2013,NCI,5R01CA138533-04,,Multifunctional Nanotherapeutics for Cancer Treatment and Imaging,"MINKO, TAMARA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$291,555"
Ovarian Cancer,2013,NCI,5R01CA149260-04,,Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy,"KUO, MACUS",UT MD ANDERSON CANCER CTR,TX,"$298,935"
Ovarian Cancer,2013,NCI,5K07CA143047-04,,Genetic Epidemiology of Ovarian and Prostate Cancer,"SIEH, WEIVA",STANFORD UNIVERSITY,CA,"$173,223"
Ovarian Cancer,2013,NCI,5R01CA142783-04,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA,VA,"$291,367"
Ovarian Cancer,2013,NCI,5R01CA115483-09,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$279,713"
Ovarian Cancer,2013,NCI,5R01CA135179-05,,INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$355,097"
Ovarian Cancer,2013,NIBIB,5R01EB011523-04,,Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu,"CHOI, HAK SOO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$461,610"
Ovarian Cancer,2013,NCI,5R03CA162140-02,,Parental age at birth and risk of adult-onset cancer in female offspring,"LU, YANI",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$78,960"
Ovarian Cancer,2013,NHGRI,5U01CA168409-02,,COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS,"POWERS, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$1,307,258"
Ovarian Cancer,2013,NCI,5R01CA136512-05,,BRCA1 Function in Post-Damage Nuclear Foci,"LIVINGSTON, DAVID",DANA-FARBER CANCER INST,MA,"$480,837"
Ovarian Cancer,2013,NCI,5F31CA165844-02,,Defining the role and regulation of the RhoGEF Ect2 in ovarian cancer cells,"HUFF, LAUREN",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$29,392"
Ovarian Cancer,2013,NCI,5R01CA126841-05,,Regulatory T Cell Function in Ovarian Cancer,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$542,599"
Ovarian Cancer,2013,NCI,5R01CA135006-05,,Role of TbRIII in Regulating Motility and Invasion,"BLOBE, GERARD",DUKE UNIVERSITY,NC,"$395,694"
Ovarian Cancer,2013,NCI,5R01CA160998-03,,Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$374,237"
Ovarian Cancer,2013,NCI,5R01CA149356-13,,The Role of MicroRNAs in Tumor Progression,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$255,800"
Ovarian Cancer,2013,NCI,5R01CA129142-05,,Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women,"KINNEY, ANITA",UNIVERSITY OF UTAH,UT,"$503,480"
Ovarian Cancer,2013,NCI,5P30CA006516-48,6051,Gynecologic Cancers,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$85,642"
Ovarian Cancer,2013,NCI,5R01CA151570-03,,Co-registered photoacoustic and ultrasound  imaging  for non-invasive ovarian can,"ZHU, QUING",UNIVERSITY OF CONNECTICUT STORRS,CT,"$304,531"
Ovarian Cancer,2013,NCI,5U10CA027469-33,,Gynecologic Oncology Group,"DISAIA, PHILIP",GYNECOLOGIC ONCOLOGY GROUP,MD,"$8,209,168"
Ovarian Cancer,2013,NCI,5R01CA140933-05,,Biobehavioral Influences and the Ovarian Tumor Microenvironment,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$447,202"
Ovarian Cancer,2013,NIBIB,1R01EB016582-01,,Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer,"NOLTE, DAVID",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$339,561"
Ovarian Cancer,2013,NCI,5R01CA131400-05,,VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER,"SPRINGETT, GREGORY",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$315,962"
Ovarian Cancer,2013,NCI,5K08CA151892-03,,Targeting Src Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer,"SIMPKINS, FIONA",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$161,488"
Ovarian Cancer,2013,NCI,7P50CA083638-15,7949,Gene Methylation Signatures for Predictive Classification of Response to Therapy,"CAIRNS, PAUL",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$276,221"
Ovarian Cancer,2013,NCI,7P50CA083638-15,7950,Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C,"DALY, MARY",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$412,393"
Ovarian Cancer,2013,NCI,7P50CA083638-15,7951,Therapeutic Micro RNA Strategies for Ovarian Cancer,"HAMILTON, THOMAS",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$499,351"
Ovarian Cancer,2013,NCI,7P50CA083638-15,7952,Targeting Signaling Networks Via Novel RNAi Approaches to Improve Therapy for O,"GODWIN, ANDREW",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$307,010"
Ovarian Cancer,2013,NCI,7P50CA083638-15,7955,Advancing T cell Therapy for Ovarian Cancer,"COUKOS, GEORGE",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$526,095"
Ovarian Cancer,2013,NCI,7P50CA083638-15,7956,Administrative Core,"SEIDEN, MICHAEL",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$109,842"
Ovarian Cancer,2013,NIGMS,5R21GM103536-03,,Development of Nanoproteomic Technologies,"LEE, CHENG",UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS,MD,"$180,938"
Ovarian Cancer,2013,NCI,7P30CA006927-50,8440,Histopathology,"SEIDEN, MICHAEL",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$51,910"
Ovarian Cancer,2013,NCI,5R01CA136491-05,,Development of an Assay for the Early Detection of Ovarian Cancer,"MOORE, RICHARD",WOMEN AND INFANTS HOSPITAL-RHODE ISLAND,RI,"$314,922"
Ovarian Cancer,2013,NCI,1R01CA174904-01,,Roles of Chromatin Modification in BRCA1 Dependent DNA Repair,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$332,000"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5590,"Inhibition of indole-amine 2,3 dioxygenase to Enhance Ovarian Tumor Immunity","ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$374,580"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5591,Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov,"SHRIKANT, PROTUL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$328,043"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5593,MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1,"KALINSKI, PAWEL",UNIVERSITY OF PITTSBURGH,PA,"$252,036"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5594,Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$226,305"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5595,Administrative Core,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$171,210"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5596,Biospecimen Core,"MORRISON, CARL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$170,076"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5597,Biostatistics/Medical Informatics,"HUTSON, ALAN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$130,883"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5598,Immune Monitoring Core,"WALLACE, PAUL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$232,159"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5599,Developmental Research Program,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$157,610"
Ovarian Cancer,2013,NCI,1P50CA159981-01A1,5600,Career Development Program,"LELE, SHASHIKANT",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$107,598"
Ovarian Cancer,2013,NCI,1K22CA175262-01,,Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection,"SCHLACHER, KATHARINA",SLOAN-KETTERING INST CAN RES,NY,"$200,060"
Ovarian Cancer,2013,NCI,1R01CA169200-01A1,,The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$390,552"
Ovarian Cancer,2013,NICHD,1R01HD073499-01A1,,Genetic regulation of ovariole development in Drosophila,"EXTAVOUR, CASSANDRA",HARVARD UNIVERSITY,MA,"$312,656"
Ovarian Cancer,2013,NCI,1R01CA168758-01A1,,Epidemiologic factors and survival by molecular subtypes of ovarian cancer,"ROSSING, MARY",FRED HUTCHINSON CAN RES CTR,WA,"$682,662"
Ovarian Cancer,2013,NCI,5R37CA070867-16,,Cancer Risk Reduction and Diet: A Cohort Study of Women,"ZHENG, WEI",VANDERBILT UNIVERSITY MED CTR,TN,"$894,579"
Ovarian Cancer,2013,NCI,5U19CA148112-04,8865,Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI),"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$305,598"
Ovarian Cancer,2013,NCI,5U19CA148112-04,8866,"Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)","SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$414,478"
Ovarian Cancer,2013,NCI,5U19CA148112-04,8867,Functional assessment of genes and common genetic risk variants in ovarian cancer,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$734,109"
Ovarian Cancer,2013,NCI,5U19CA148112-04,8868,Genetic and environmental interaction analyses and risk prediction modeling,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$630,069"
Ovarian Cancer,2013,NCI,4U01CA152755-04,,An integrated systems biology approach for ovarian cancer biomarker discovery,"DIAMANDIS, ELEFTHERIOS",MT SINAI HOSP-SAMUEL LUNENFELD RES INST,CANADA,"$248,982"
Ovarian Cancer,2013,NCI,5K23CA159391-02,,Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus,"PEIKERT, TOBIAS",MAYO CLINIC ROCHESTER,MN,"$164,160"
Ovarian Cancer,2013,NIGMS,5R01GM032136-31,,Molecular Recognition of Proteins and Ligand Design,"JORGENSEN, WILLIAM",YALE UNIVERSITY,CT,"$356,731"
Ovarian Cancer,2013,NCI,5U01CA084955-14,,Atlantic Breast and Gynecologic Clinical Validation Center,"MARKS, JEFFREY",DUKE UNIVERSITY,NC,"$468,371"
Ovarian Cancer,2013,NCI,5U01CA152637-04,,Breast and Ovary Cancer Clinical Validation Center,"LI, CHRISTOPHER",FRED HUTCHINSON CAN RES CTR,WA,"$881,335"
Ovarian Cancer,2013,NCI,1R01CA169604-01A1,,Metabolic changes in ovarian cancer cells initiated by metastasis to adipose tiss,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$327,850"
Ovarian Cancer,2013,NCI,4R01CA075334-16,,MRI studies of angiogenesis in ovarian cancer,"NEEMAN, MICHAL",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$96,605"
Ovarian Cancer,2013,NCI,7R21CA164839-02,,Linking tumor chemoresistance to TLR variants that mediate damage chain reaction,"SCHOLLER, NATHALIE",SRI INTERNATIONAL,CA,"$174,063"
Ovarian Cancer,2013,NCI,5R01CA085566-10,,Psychological Intervention for Ovarian Cancer Patients,"MANNE, SHARON",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$447,164"
Ovarian Cancer,2013,NCI,1K07CA166210-01A1,,Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer,"WRIGHT, ALEXI",DANA-FARBER CANCER INST,MA,"$177,120"
Ovarian Cancer,2013,NCI,1R21CA169739-01A1,,Integration and Evaluation of Pooled Cancer Studies with Heterogeneity,"LIU, MENGLING",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$197,558"
Ovarian Cancer,2013,NCI,5R01CA160541-03,,Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer,"TAINSKY, MICHAEL",WAYNE STATE UNIVERSITY,MI,"$296,476"
Ovarian Cancer,2013,NCCAM,5R01AT005295-03,,Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer,"HALES, DALE",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$349,309"
Ovarian Cancer,2013,NCI,7R01CA163018-02,,Prospective Study of Serum MIS and Gynecologic Cancer Risk,"DORGAN, JOANNE",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$437,025"
Ovarian Cancer,2013,NCI,5F32CA159523-03,,Understanding the origin and pathogenesis of epithelial ovarian cancer,"KIM, JAEYEON",BAYLOR COLLEGE OF MEDICINE,TX,"$57,734"
Ovarian Cancer,2013,NCI,5U01CA152990-04,,"Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery","SKATES, STEVEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$672,847"
Ovarian Cancer,2013,NCI,5P01CA087969-14,7547,Ovarian Cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$365,128"
Ovarian Cancer,2013,NCI,5P01CA087969-14,7548,Statistical Methods,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$340,500"
Ovarian Cancer,2013,NCI,5P01CA087969-14,7551,Biologic Specimen Management Core,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$482,207"
Ovarian Cancer,2013,NIAID,5SC1AI089073-05,,Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,"SON, DEOK-SOO",MEHARRY MEDICAL COLLEGE,TN,"$337,425"
Ovarian Cancer,2013,NCI,5R01CA158318-03,,mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$318,433"
Ovarian Cancer,2013,NCI,5F32CA159558-03,,Role of p190RhoGEF (Rgnef) in cell motility and tumor progression,"MILLER, NICHOL",UNIVERSITY OF CALIFORNIA,CA,"$57,734"
Ovarian Cancer,2013,NCI,5R01CA160669-02,,Mitochondrial DNA and Ovarian Cancer Risk and Survival,"COOK, LINDA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$446,270"
Ovarian Cancer,2013,NCI,5R21CA155424-03,,Enzyme-delivery scaffold technology for targeted cancer killing.,"LAVIE, ARNON",UNIVERSITY OF ILLINOIS,IL,"$186,663"
Ovarian Cancer,2013,NCI,5U24CA160036-03,,Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers,"CHAN, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$1,824,239"
Ovarian Cancer,2013,NCI,5R03CA165082-02,,Identification of regulatory cancer risk SNPs for chemoprevention discovery,"KLEIN, ROBERT",SLOAN-KETTERING INST CAN RES,NY,"$85,963"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7964,Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women,"URBAN, NICOLE",FRED HUTCHINSON CAN RES CTR,WA,"$138,833"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7965,Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V,"DRESCHER, CHARLES",FRED HUTCHINSON CAN RES CTR,WA,"$254,872"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7966,MicroRNA Signature of Poorly Resectable Ovarian Cancer,"TEWARI, MUNEESH",FRED HUTCHINSON CAN RES CTR,WA,"$191,673"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7967,Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CAN RES CTR,WA,"$262,827"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7968,Vaccinating against IGFBP-2 to prevent ovarian cancer relapse,"DISIS, MARY",UNIVERSITY OF WASHINGTON,WA,"$321,413"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7969,Leadership and Administration Core,"URBAN, NICOLE",FRED HUTCHINSON CAN RES CTR,WA,"$143,287"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7970,Clinical Specimen Management and Characterization Core,"KNUDSEN, BEATRICE",FRED HUTCHINSON CAN RES CTR,WA,"$272,427"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7971,"Participant Recruitment, Enrollment and Characterization Core","DRESCHER, CHARLES",FRED HUTCHINSON CAN RES CTR,WA,"$232,523"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7972,Biostatistics and Informatics Core,"MCINTOSH, MARTIN",FRED HUTCHINSON CAN RES CTR,WA,"$211,505"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7973,Developmental Research Program,"MCINTOSH, MARTIN",FRED HUTCHINSON CAN RES CTR,WA,"$60,570"
Ovarian Cancer,2013,NCI,5P50CA083636-15,7974,Career and Mentoring Development Program,"COLLINS, STEVEN",FRED HUTCHINSON CAN RES CTR,WA,"$60,569"
Ovarian Cancer,2013,NCI,5F31CA165528-02,,The Functional Analysis of Ovarian Cancer Susceptibility Locus 9p22.2,"BUCKLEY, MELISSA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$42,232"
Ovarian Cancer,2013,NCI,5R21CA164593-02,,Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer,"ANDERSON, KAREN",ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,AZ,"$155,627"
Ovarian Cancer,2013,NCI,1F32CA177094-01,,Peptide-mediated delivery of siRNA for treatment of ovarian cancer,"KWON, ESTER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$53,942"
Ovarian Cancer,2013,NCI,5F31CA159804-03,,Integrin Linked Kinase and Ovarian Cancer Metastasis,"BRUNEY, LANA",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$28,690"
Ovarian Cancer,2013,NCI,5R01CA112240-08,,The role of Fas as tumor promoter,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$276,499"
Ovarian Cancer,2013,NCI,5R01CA068682-22,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$301,027"
Ovarian Cancer,2013,NCI,5R21CA170195-02,,An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9),"DUPUY, ADAM",UNIVERSITY OF IOWA,IA,"$185,232"
Ovarian Cancer,2013,NCI,1R21CA177233-01,,Novel Tools for Familial Risk Prediction,"PARMIGIANI, GIOVANNI",DANA-FARBER CANCER INST,MA,"$225,021"
Ovarian Cancer,2013,NHLBI,5R44HL099217-03,,ChNKG2D-Targeted Cellular Cancer Therapy: Phase I Clinical Trial,"FANGER, MICHAEL","CELDARA MEDICAL, LLC",NH,"$1,819,563"
Ovarian Cancer,2013,NCI,5K05CA136967-05,,Research and Mentoring on Energetic Factors and Cancer: Established Investigator,"BERNSTEIN, LESLIE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$139,821"
Ovarian Cancer,2013,NCI,5R01CA163377-02,,Role of EZH2 in Epithelial Ovarian Cancer,"ZHANG, RUGANG",WISTAR INSTITUTE,PA,"$297,198"
Ovarian Cancer,2013,NCI,5R01CA111882-07,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$255,979"
Ovarian Cancer,2013,NCI,5R33CA155618-03,,Array Microscope Assay for Cancer Cell Mechanics,"SUPERFINE, RICHARD",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$307,678"
Ovarian Cancer,2013,NCI,5R01CA164729-02,,"Integrative Cancer Genomics: Drivers, Pathways and Drugs","PE'ER, DANA",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$358,131"
Ovarian Cancer,2013,NCI,5R01CA164122-02,,B7-H1 Signaling in Ovarian Cancer,"CURIEL, TYLER","UNIV OF TX HSC, SA",TX,"$291,600"
Ovarian Cancer,2013,NIAID,5K06AI004739-52,,BIOCHEMISTRY OF VIRAL REPLICATION,"GREEN, MAURICE",SAINT LOUIS UNIVERSITY,MO,"$33,939"
Ovarian Cancer,2013,NCI,5U01CA151461-04,,Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer,"O'HALLORAN, THOMAS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$406,358"
Ovarian Cancer,2013,NIGMS,5R01GM097495-03,,"Cross-talk between PKA, cellular tension, and Ca2+ channels during cell migration","HOWE, ALAN",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$279,609"
Ovarian Cancer,2013,NCI,5U54CA151881-04,5122,Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA,"TORCHILIN, VLADIMIR",NORTHEASTERN UNIVERSITY,MA,"$700,412"
Ovarian Cancer,2013,NCI,5U54CA151881-04,5124,Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance,"MINKO, TAMARA",RUTGERS THE STATE UNIVERSITY OF NJ,NJ,"$247,064"
Ovarian Cancer,2013,NCI,7U01CA168870-02,,Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer,"ABBOTT, KAREN",UNIV OF ARKANSAS FOR MED SCIS,AR,"$359,689"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7762,P1 - Early Detection of Epithelial Ovarian Cancer,"BAST, ROBERT",UT MD ANDERSON CANCER CTR,TX,"$276,947"
Ovarian Cancer,2013,OD,5P50CA083639-14,7762,P1 - Early Detection of Epithelial Ovarian Cancer,"BAST, ROBERT",UT MD ANDERSON CANCER CTR,TX,"$2,456"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7764,P2 - Targeting DII4-Notch Signaling in Ovarian Cancer,"SOOD, ANIL",UT MD ANDERSON CANCER CTR,TX,"$251,487"
Ovarian Cancer,2013,OD,5P50CA083639-14,7764,P2 - Targeting DII4-Notch Signaling in Ovarian Cancer,"SOOD, ANIL",UT MD ANDERSON CANCER CTR,TX,"$2,231"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7767,P3 - Personalized Therapy for Low-Grade Serous Carcinoma of the Ovary,"GERSHENSON, DAVID",UT MD ANDERSON CANCER CTR,TX,"$252,541"
Ovarian Cancer,2013,OD,5P50CA083639-14,7767,P3 - Personalized Therapy for Low-Grade Serous Carcinoma of the Ovary,"GERSHENSON, DAVID",UT MD ANDERSON CANCER CTR,TX,"$2,240"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7768,P4 - Pers. Therapy for High-Grade Ovarian Cancer: Targeting PI3Kness & BRCAne,"MILLS, GORDON",UT MD ANDERSON CANCER CTR,TX,"$228,872"
Ovarian Cancer,2013,OD,5P50CA083639-14,7768,P4 - Pers. Therapy for High-Grade Ovarian Cancer: Targeting PI3Kness & BRCAne,"MILLS, GORDON",UT MD ANDERSON CANCER CTR,TX,"$2,030"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7770,P5 - Gene-modified MSCs for Controlling Ovarian Cancer,"MARINI, FRANK",UT MD ANDERSON CANCER CTR,TX,"$232,277"
Ovarian Cancer,2013,OD,5P50CA083639-14,7770,P5 - Gene-modified MSCs for Controlling Ovarian Cancer,"MARINI, FRANK",UT MD ANDERSON CANCER CTR,TX,"$2,060"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7771,Administrative Core,"GERSHENSON, DAVID",UT MD ANDERSON CANCER CTR,TX,"$80,362"
Ovarian Cancer,2013,OD,5P50CA083639-14,7771,Administrative Core,"GERSHENSON, DAVID",UT MD ANDERSON CANCER CTR,TX,$713
Ovarian Cancer,2013,NCI,5P50CA083639-14,7772,"Biostatistics, Bioinformatics and Systems Biology (BBSB) Core","ATKINSON, E",UT MD ANDERSON CANCER CTR,TX,"$327,277"
Ovarian Cancer,2013,OD,5P50CA083639-14,7772,"Biostatistics, Bioinformatics and Systems Biology (BBSB) Core","ATKINSON, E",UT MD ANDERSON CANCER CTR,TX,"$2,903"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7773,Pathology Core,"BROADDUS, RUSSELL",UT MD ANDERSON CANCER CTR,TX,"$170,868"
Ovarian Cancer,2013,OD,5P50CA083639-14,7773,Pathology Core,"BROADDUS, RUSSELL",UT MD ANDERSON CANCER CTR,TX,"$1,516"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7774,Developmental Research Program,"GERSHENSON, DAVID",UT MD ANDERSON CANCER CTR,TX,"$135,123"
Ovarian Cancer,2013,OD,5P50CA083639-14,7774,Developmental Research Program,"GERSHENSON, DAVID",UT MD ANDERSON CANCER CTR,TX,"$1,198"
Ovarian Cancer,2013,NCI,5P50CA083639-14,7775,Career Developmental Program,"GERSHENSON, DAVID",UT MD ANDERSON CANCER CTR,TX,"$108,626"
Ovarian Cancer,2013,OD,5P50CA083639-14,7775,Career Developmental Program,"GERSHENSON, DAVID",UT MD ANDERSON CANCER CTR,TX,$963
Ovarian Cancer,2013,NCI,5U54CA151459-04,8855,Next Generation Smart Nanoparticles,"RAO, JIANGHONG",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$934,934"
Ovarian Cancer,2013,NCI,5U54CA151459-04,8856,Magneto-Nano Diagnostic and Analytical Devices for Cancer,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$235,231"
Ovarian Cancer,2013,NCI,5U54CA151459-04,8858,Integration of Nano-Molecular Imaging and Nanosensors,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$156,925"
Ovarian Cancer,2013,NCI,5U54CA151459-04,8865,Pilot Projects,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$53,278"
Ovarian Cancer,2013,NCI,5K08CA163603-02,,Antibody directed delivery of short interfering RNA for the treatment of ovarian,"PALANCA-WESSELS, MARIA",FRED HUTCHINSON CAN RES CTR,WA,"$170,631"
Ovarian Cancer,2013,NCI,7R01CA157481-02,,"Bmi-1, a potential therapeutic target in ovarian cancer","BHATTACHARYA, RESHAM",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$304,071"
Ovarian Cancer,2013,NCI,5K22CA166226-02,,Targeting c-MYC Overcomes Temsirolimus and Cisplatin Resistance of Ovarian Cancer,"VIVAS-MEJIA, PABLO",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$172,265"
Ovarian Cancer,2013,NCI,5R33CA147988-03,,Development and Application of Novel Glycan-Specific Reagents to Facilitate Early,"MUDDIMAN, DAVID",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$332,549"
Ovarian Cancer,2013,NCI,5K01CA172591-02,,"EGF receptor, DNA methylation and platinum resistance in ovarian cancer","SAMUDIO-RUIZ, SABRINA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$114,405"
Ovarian Cancer,2013,NCI,5P30CA118100-09,6320,Womens Cancers Research Program,"PROSSNITZ, ERIC",UNIVERSITY OF NEW MEXICO,NM,"$37,956"
Ovarian Cancer,2013,NCI,5U54CA151662-04,8769,Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer,"GERNGROSS, TILLMAN",DARTMOUTH COLLEGE,NH,"$240,040"
Ovarian Cancer,2013,NCI,5U54CA151662-04,8772,Magnetic nanoparticle Immunotherapy against Ovarian Cancer,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$287,485"
Ovarian Cancer,2013,NCI,5U54CA151662-04,8775,"Toxicology, Pathology and Biodistribution Core (TPB Core)","LEWIS, LIONEL",DARTMOUTH COLLEGE,NH,"$159,823"
Ovarian Cancer,2013,NCI,5R01CA163451-02,,"Psychological stress, associate biologic mediators, and ovarian cancer risk","TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$389,016"
Ovarian Cancer,2013,NCI,5U54CA151819-04,8878,"Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an","HOOD, LEROY",INSTITUTE FOR SYSTEMS BIOLOGY,WA,"$649,409"
Ovarian Cancer,2013,NCI,5U54CA151819-04,8879,Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy,"RADU, CAIUS",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$342,009"
Ovarian Cancer,2013,NCI,5U54CA151819-04,8883,Administrative Core,"HEATH, JAMES",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$104,293"
Ovarian Cancer,2013,NCI,5R21CA165916-02,,Models for Consortium Level Analysis of GxE Interaction in Complex Disease,"IVERSEN, EDWIN",DUKE UNIVERSITY,NC,"$128,395"
Ovarian Cancer,2013,NICHD,5R00HD059985-04,,GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer,"WANG, CHENG",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$230,894"
Ovarian Cancer,2013,NCI,5U54CA151884-04,5023,Nanoformulations for siRNA Delivery to Ovarian Cancer,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$252,012"
Ovarian Cancer,2013,NCI,7R01CA151374-04,,Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients,"MARTIN, LAINIE",RESEARCH INST OF FOX CHASE CAN CTR,PA,$1
Ovarian Cancer,2013,NCI,5F30CA171715-02,,Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer,"LOU, DIANNE","UNIVERSITY OF TEXAS, AUSTIN",TX,"$32,232"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7923,Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$304,054"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7924,Mechanisms of Immune Suppression in Ovarian Cancer,"KNUTSON, KEITH",MAYO CLINIC ROCHESTER,MN,"$209,136"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7925,Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer,"GALANIS, EVANTHIA",MAYO CLINIC ROCHESTER,MN,"$393,649"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7926,Flavopiridol Reverses Platinum Resistance in Ovarian Cancer,"BIBLE, KEITH",MAYO CLINIC ROCHESTER,MN,"$219,848"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7927,Administration Core,"HARTMANN, LYNN",MAYO CLINIC ROCHESTER,MN,"$138,222"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7928,Biospecimens/Patient Registry Core,"BELL, DEBRA",MAYO CLINIC ROCHESTER,MN,"$217,100"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7929,Biostatistics Core,"OBERG, ANN",MAYO CLINIC ROCHESTER,MN,"$273,526"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7930,Animal Models,"KNUTSON, KEITH",MAYO CLINIC ROCHESTER,MN,"$171,968"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7931,Developmental Research Program,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$148,656"
Ovarian Cancer,2013,NCI,5P50CA136393-05,7932,Career Development Program,"COUCH, FERGUS",MAYO CLINIC ROCHESTER,MN,"$74,332"
Ovarian Cancer,2013,RMAP,5R03MH097507-02,,Molecular probes for a vOTU from CCHFV using a fluorogenic peptide,"PEGAN, SCOTT",UNIVERSITY OF DENVER (COLORADO SEMINARY),CO,"$35,745"
Ovarian Cancer,2013,NCI,5F31CA168180-02,,A novel model system for risk assessment of BRCA carriers,"COCHRAN, RORY",JOHNS HOPKINS UNIVERSITY,MD,"$42,232"
Ovarian Cancer,2013,RMAP,5R03MH097485-02,,Discovering modulators of PAX8 for targeting ovarian cancer,"HAHN, WILLIAM",DANA-FARBER CANCER INST,MA,"$42,438"
Ovarian Cancer,2013,NCI,5U01CA151648-05,,RNA Nanotechnology in Cancer Therapy,"GUO, PEIXUAN",UNIVERSITY OF KENTUCKY,KY,"$374,523"
Ovarian Cancer,2013,NCI,5F30CA167895-02,,Molecular analysis of the function of BRCA1-TONSL complexes,"HILL, SARAH",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$44,874"
Ovarian Cancer,2013,NCI,5U54CA151668-04,8844,Multistage Vectors (MSV) for Ovarian Cancer Therapeutics,"LOPEZ-BERESTEIN, GABRIEL",UT MD ANDERSON CANCER CTR,TX,"$287,116"
Ovarian Cancer,2013,NCI,5U54CA151668-04,8845,Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature,"SOOD, ANIL",UT MD ANDERSON CANCER CTR,TX,"$272,924"
Ovarian Cancer,2013,NCI,5U54CA151668-04,8847,Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri,"ARAP, WADIH",UT MD ANDERSON CANCER CTR,TX,"$228,173"
Ovarian Cancer,2013,NCI,5U54CA163068-02,8073,Identifying Cancer Health Communication Channels for Hispanic Audiences,"QUINN, GWENDOLYN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$76,422"
Ovarian Cancer,2013,NCI,5U54CA163071-02,7991,Identifying Cancer Health Communication Channels for Hispanic Audiences,"JIMENEZ, JUILO",PONCE SCHOOL OF MEDICINE,PR,"$90,700"
Ovarian Cancer,2013,NCI,5R44CA139841-03,,A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC,"PRABHAKARPANDIAN, BALABHASKAR",CFD RESEARCH CORPORATION,AL,"$619,304"
Ovarian Cancer,2013,NCI,5R01CA124515-08,,Vascular Leukocytes Influence the Tumor Microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$297,976"
Ovarian Cancer,2013,NCI,5R01CA164940-02,,A Novel Approach for the Routine Screening for Ovarian Cancer,"PANNELL, LEWIS",UNIVERSITY OF SOUTH ALABAMA,AL,"$399,736"
Ovarian Cancer,2013,NCI,1R01CA177909-01,,Platelets promote growth of ovarian cancer,"AFSHAR-KHARGHAN, VAHID",UT MD ANDERSON CANCER CTR,TX,"$332,000"
Ovarian Cancer,2013,NCI,1R01CA178535-01,,The contribution of rare alleles to ovarian cancer in the population,"GAYTHER, SIMON",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$658,630"
Ovarian Cancer,2013,NCI,5P30CA046592-25,6455,Cancer Genetics,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$238,509"
Ovarian Cancer,2013,NCI,5P30CA015704-39,5475,THERAPEUTIC MANUFACTURING,"HARTWELL, LELAND",FRED HUTCHINSON CAN RES CTR,WA,"$490,937"
Ovarian Cancer,2013,NCI,1R21CA177865-01,,Defining SPINK1 as a tumor driver and therapeutic target in ovarian cancer,"RADISKY, EVETTE",MAYO CLINIC  JACKSONVILLE,FL,"$218,961"
Ovarian Cancer,2013,NCI,1R01CA178687-01,,Effects of common polymorphisms in immune sensors in tumor immunosurveillance,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$392,191"
Ovarian Cancer,2013,NCI,1K99CA179137-01,,"Understanding the origin,initiation,and progression of high-grade serous ovarian","KIM, JAEYEON",BAYLOR COLLEGE OF MEDICINE,TX,"$97,200"
Ovarian Cancer,2013,NCI,5P01CA154292-03,5435,Risk Assessment in Community Practice: Developing Better Models,"KERLIKOWSKE, KARLA",GROUP HEALTH COOPERATIVE,WA,"$538,798"
Ovarian Cancer,2013,NCI,5U54CA118638-08,5404,BRCA1 Deficiency and Epithelial Ovarian Cancers,"RAO, VEENA",MOREHOUSE SCHOOL OF MEDICINE,GA,"$82,211"
Ovarian Cancer,2013,NCI,1R21CA178571-01,,Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives,"PEARCE, CELESTE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$216,805"
Ovarian Cancer,2013,OD,1R21CA179443-01,,Validation of a risk assessment decision rule for epithelial ovarian cancer,"URBAN, NICOLE",FRED HUTCHINSON CAN RES CTR,WA,"$229,680"
Ovarian Cancer,2013,NCI,1R15CA179214-01,,Mechanisms of WNT7A-FGF1 signaling and their therapeutic potential in ovarian can,"HAYASHI, KANAKO",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$442,500"
Ovarian Cancer,2013,NCI,5F31CA174316-02,,Structural mutation analysis of PTEN and its possible genotype-phenotype correlat,"SMITH, IRIS",UNIVERSITY OF HOUSTON,TX,"$27,734"
Ovarian Cancer,2013,NCI,2R01CA131407-06A1,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$353,042"
Ovarian Cancer,2013,NCI,1R01CA172404-01A1,,Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer,"RAMUS, SUSAN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$661,659"
Ovarian Cancer,2013,NCI,9R01CA180769-05,,Signaling Connections Controlling Cell Motility and Invasion,"SCHLAEPFER, DAVID",UNIVERSITY OF CALIFORNIA,CA,"$367,200"
Ovarian Cancer,2013,NCI,1R01CA172272-01A1,,The BARD1 tumor suppressor and breast cancer,"BAER, RICHARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Ovarian Cancer,2013,RMAP,1UH2TR000943-01,,Novel extra cellular RNA-based combinatorial RNA inhibition therapy,"SOOD, ANIL",UT MD ANDERSON CANCER CTR,TX,"$500,000"
Ovarian Cancer,2013,NCI,1R21CA179680-01,,A Novel IgE Cancer Therapeutic Specific for the Epithelial Membrane Protein-2,"DANIELS-WELLS, TRACY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$167,475"
Ovarian Cancer,2013,NCI,3R01CA079716-14S1,,Ovarian Cancer: Epithelial Dedifferentiation,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$48,057"
Ovarian Cancer,2013,NCI,1R21CA180145-01,,(PQD3) The role and therapeutic potential of ZNF304 in Ovarian Cancer,"OZPOLAT, BULENT",UT MD ANDERSON CANCER CTR,TX,"$208,800"
Ovarian Cancer,2013,NIGMS,2R44GM086937-02,,New Reagents for RNA-based Therapeutic Technologies,"YANG, XIANBIN","AM BIOTECHNOLOGIES, LLC",TX,"$519,358"
Ovarian Cancer,2013,NCI,1R01CA175480-01A1,,Tumor-targeted Polymersomes to image and Treat Ovarian Cancer,"CHENG, ZHILIANG",UNIVERSITY OF PENNSYLVANIA,PA,"$342,934"
Ovarian Cancer,2013,NHGRI,3U01CA168409-01S1,,COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS,"POWERS, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$250,000"
Ovarian Cancer,2013,NIBIB,1F32EB017614-01,,LbL Nanotechnologies for Synergistic Therapy of Advanced Ovarian Carcinoma,"DREADEN, ERIK",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$49,214"
Ovarian Cancer,2013,NCI,1F32CA180677-01,,Regulation of the miRNA-directed Reprogramming of Normal Omental Fibroblasts,"KOHLHAPP, FREDERICK",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$49,214"
Ovarian Cancer,2013,NCI,4R00CA139006-03,,Development of Targeted Therapy for ERK Pathway in Breast Cancer,"BARTHOLOMEUSZ, CHANDRA",UT MD ANDERSON CANCER CTR,TX,"$234,059"
Ovarian Cancer,2013,NCI,3R01CA133117-05S1,,Role of the Mullerian Tract in Ovarian Cancer Development,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$27,440"
Ovarian Cancer,2013,NCI,3R01CA149669-04S1,,CD73 and Tumor Immunity-CD73 and CTLA-4 combination Blockade in Ovarian Cancer,"ZHANG, BIN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$55,294"
Ovarian Cancer,2013,RMAP,3DP2OD007391-01S2,,ULTRASENSITIVE NANOLASERS FOR EPIGENETICS INVESTIGATIONS,"ARMANI, ANDREA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$148,181"
Ovarian Cancer,2013,NCI,2U54CA096300-11,6961,In Vivo Assessment of Localized Magnetic Fluid Hyperthermia for Ovarian Cancer,"SOOD, ANIL",UNIVERSITY OF PUERTO RICO,PR,"$91,854"
Ovarian Cancer,2013,NCI,1R21CA177048-01A1,,Role of Malic Enzymes in Tumorigenesis,"YANG, XIAOLU",UNIVERSITY OF PENNSYLVANIA,PA,"$174,000"
Ovarian Cancer,2013,NCI,3R41CA168228-01A1S1,,Integrin Targeted Therapy for the Treatment of Ovarian Cancer,"CALZONE, FRANK","APPLIED INTEGRIN SCIENCES, INC.",CA,"$158,842"
Ovarian Cancer,2013,NCI,3R41CA162648-01S1,,Development of Novel Agents Targeting Genome Stability and Maintenance for Treati,"TURCHI, JOHN","NERX BIOSCIENCES, INC.",IN,"$131,247"
Ovarian Cancer,2013,NCI,1R01CA180710-01A1,,Targeting nucleotide excision repair in combination cancer therapy,"TURCHI, JOHN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$323,700"
Ovarian Cancer,2013,NCI,261200800001E-52-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$1,692,154"
Ovarian Cancer,2013,NCI,3R01CA140933-05S1,,Biobehavioral Influences and the Ovarian Tumor Microenvironment,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$44,314"
Ovarian Cancer,2013,NCI,3R01CA115483-09S1,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$47,539"
Ovarian Cancer,2013,NCI,3R01CA142783-04S1,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA,VA,"$55,147"
Ovarian Cancer,2013,NCI,3R01CA140323-04S1,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$73,478"
Ovarian Cancer,2013,NCI,3P30CA082709-14S4,0003,Senior Leaders,"WILLIAMS, STEPHEN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$5,358"
Ovarian Cancer,2013,NCI,3R01CA047135-23A1S1,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$47,173"
Ovarian Cancer,2013,NCI,3R01CA135006-05S1,,Role of TbRIII in Regulating Motility and Invasion,"BLOBE, GERARD",DUKE UNIVERSITY,NC,"$50,873"
Ovarian Cancer,2013,NCI,3P30CA118100-09S2,6320,Womens Cancers Research Program,"PROSSNITZ, ERIC",UNIVERSITY OF NEW MEXICO,NM,"$6,251"
Ovarian Cancer,2013,NCI,3R33CA147988-03S1,,Development and Application of Novel Glycan-Specific Reagents to Facilitate Early,"MUDDIMAN, DAVID",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$52,110"
Ovarian Cancer,2013,RMAP,3U01CA152637-04S1,,Breast and Ovary Cancer Clinical Validation Center,"LI, CHRISTOPHER",FRED HUTCHINSON CAN RES CTR,WA,"$165,129"
Ovarian Cancer,2013,RMAP,3R01CA163018-02S1,,Prospective Study of Serum MIS and Gynecologic Cancer Risk,"DORGAN, JOANNE",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$124,545"
Ovarian Cancer,2013,NCI,3R01CA140323-04S2,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$57,988"
Ovarian Cancer,2013,NCI,3P50CA083639-14W1,7762,Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer,"BAST, ROBERT",UT MD ANDERSON CANCER CTR,TX,"$31,250"
Ovarian Cancer,2013,OD,3P50CA083639-14W1,7762,Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer,"BAST, ROBERT",UT MD ANDERSON CANCER CTR,TX,"$18,750"
Ovarian Cancer,2013,NIEHS,1ZIAES021231-14,,Effects of COX-1 or COX-2 Deficiency on Mouse Skin Cancer,"LANGENBACH, ROBERT",NIH,,"$120,829"
Ovarian Cancer,2013,NIEHS,1ZIAES049032-17,,Environmental Exposure and DNA Damage,"TAYLOR, JACK",NIH,,"$581,798"
Ovarian Cancer,2013,NIA,1ZIAAG000395-06,,Expression and roles of claudin-3 and claudin-4 in ovarian cancer,"SEN, RANJAN",NIH,,"$902,167"
Ovarian Cancer,2013,NIA,1ZIAAG000396-06,,Mechanisms of drug resistance in ovarian cancer,"SEN, RANJAN",NIH,,"$216,977"
Ovarian Cancer,2013,NIA,1ZIAAG000397-06,,Claudin-7 in ovarian cancer,"SEN, RANJAN",NIH,,"$289,303"
Ovarian Cancer,2013,NIA,1ZIAAG000398-06,,Expression and roles of microRNAs in ovarian tumorigenesis,"SEN, RANJAN",NIH,,"$403,501"
Ovarian Cancer,2013,NCI,N1CN75022A-74-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$783,164"
Ovarian Cancer,2013,NCI,N1CN25476A-90-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","O'BRIEN, BARBARA","WESTAT, INC.",MD,"$1,935,456"
Ovarian Cancer,2013,NIAID,1ZIAAI001038-06,,Mechanisms of Antitumor Action of Human Interferon,"ZOON, KATHRYN",NIH,,"$214,340"
Ovarian Cancer,2013,NHGRI,1ZIAHG000120-17,,The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer,"BRODY, LAWRENCE",NIH,,"$161,619"
Ovarian Cancer,2013,NHGRI,1ZIAHG200323-09,,"Genomic, Epigenetic and Functional Analyses of Vertebrate Regulatory Regions","ELNITSKI, LAURA",NIH,,"$1,216,969"
Ovarian Cancer,2013,NCI,261200800001E-52-0-116,,Pilot Projects TCGA Tumor Samples,"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$540,000"
Ovarian Cancer,2013,NCI,5U54CA118948-08,6387,Project 2 Landen_Rao,"MANNE, UPENDER",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$24,297"
Ovarian Cancer,2013,NCI,1ZIABC006161-30,,DNA Topoisomerases as Target of Action of Anticancer Drugs,"POMMIER, YVES",NIH,,"$932,263"
Ovarian Cancer,2013,NCI,1ZIABC009052-24,,Papillomavirus Virion Proteins and Vaccines,"SCHILLER, JOHN",NIH,,"$1,919,421"
Ovarian Cancer,2013,NCI,1ZIABC010027-19,,Function of Steroid Receptors in Subcellular Compartments,"HAGER, GORDON",NIH,,"$683,097"
Ovarian Cancer,2013,NCI,1ZIABC010549-11,,Zebrafish Models of Cancer,"HICKSTEIN, DENNIS",NIH,,"$590,272"
Ovarian Cancer,2013,NCI,1ZIABC010657-09,,Intracellular In vivo Imaging,"CHOYKE, PETER",NIH,,"$1,229,175"
Ovarian Cancer,2013,NCI,1ZIABC010661-09,,Vaccine and Drug Combination Therapy for Human Cancers,"HODGE, JAMES",NIH,,"$524,358"
Ovarian Cancer,2013,NCI,1ZIABC010830-07,,Mechanisms of non-classical multidrug resistance in cancer,"GOTTESMAN, MICHAEL",NIH,,"$880,230"
Ovarian Cancer,2013,NCI,1ZIABC011054-06,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$828,564"
Ovarian Cancer,2013,NCI,1ZIABC011055-06,,Serum Antibody Profiling with a Carbohydrate Microarray,"GILDERSLEEVE, JEFF",NIH,,"$543,615"
Ovarian Cancer,2013,NCI,1ZIABC011188-05,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$730,343"
Ovarian Cancer,2013,NCI,1ZIABC011197-05,,Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,"APPELLA, ETTORE",NIH,,"$591,793"
Ovarian Cancer,2013,NCI,1ZIABC011311-04,,Identification of genetic interactors of Brca2,"SHARAN, SHYAM",NIH,,"$323,792"
Ovarian Cancer,2013,NCI,1ZIABC011315-04,,Molecular characterization of endometrial cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$207,141"
Ovarian Cancer,2013,NCI,1ZIABC011353-04,,Development and validation of preclinical mouse model for serous ovarian cancer,"VAN DYKE, TERRY",NIH,,"$848,130"
Ovarian Cancer,2013,NCI,1ZIABC011521-01,,Combination Studies in Prostat Cancer,"MADAN, RAVI",NIH,,"$75,508"
Ovarian Cancer,2013,NCI,1ZIABC011525-01,,Targeting DNA damage repair and related pathways in HRD-womens cancers,"LEE, JUNG-MIN",NIH,,"$141,489"
Ovarian Cancer,2013,NCI,1ZIACP010126-18,,Hormone-Related Cancers,"BRINTON, LOUISE",NIH,,"$5,262,671"
Ovarian Cancer,2013,NCI,1ZIACP010128-18,,Therapeutic and Diagnostic Factors as Related to Cancer Risk,"BRINTON, LOUISE",NIH,,"$446,543"
Ovarian Cancer,2013,NCI,1ZIACP010144-15,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"GREENE, MARK",NIH,,"$5,155,247"
Ovarian Cancer,2013,NCI,1ZIACP010145-14,,Intervention Trials in Persons at Increased Genetic Risk of Cancer,"GREENE, MARK",NIH,,"$1,537,139"
Ovarian Cancer,2013,NCI,1ZIACP010152-14,,PLCO Trial Etiologic and Early Marker Study,"HOOVER, ROBERT",NIH,,"$1,915,866"
Ovarian Cancer,2013,NCI,1ZIACP010182-11,,Epidemiologic Field Studies,"GAIL, MITCHELL",NIH,,"$482,775"
Ovarian Cancer,2013,NCI,1ZIACP010183-11,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$167,685"
Ovarian Cancer,2013,NCI,1ZIACP010187-09,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$186,238"
Ovarian Cancer,2013,NCI,1ZIACP010188-09,,Risk prediction methods,"GAIL, MITCHELL",NIH,,"$648,755"
Ovarian Cancer,2013,NCI,1ZIACP010207-04,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$761,919"
Ovarian Cancer,2013,NCI,1ZIASC006353-31,,Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"BRECHBIEL, MARTIN",NIH,,"$1,147,554"
Ovarian Cancer,2013,NCI,1ZIASC009163-26,,Signal Transduction Therapy--Basic Science,"KOHN, ELISE",NIH,,"$244,636"
Ovarian Cancer,2013,NCI,1ZIASC009374-22,,Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,"KOHN, ELISE",NIH,,"$244,636"
Ovarian Cancer,2013,NCI,1ZIASC009375-21,,Signal Transduction Therapy--Clinical,"KOHN, ELISE",NIH,,"$459,914"
Ovarian Cancer,2013,NCI,1ZIEBC011136-05,,The CCRWalter Reed Army Medical Center Gynecologic Cancer Program Research Lab,"KOHN, ELISE",NIH,,"$29,356"
Ovarian Cancer,2013,NCI,261201300008I-0-26100004-1,,"The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Medication User Questio","DAVIS, TERISA","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$113,180"
